Optimization of testing times and critical values in sequential equivalence testing
Related Experiment Video
Updated: Oct 19, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
1Institute of Medical Biometry, Philipps-University of Marburg, Bunsenstrasse 3, D-35037 Marburg, Germany.
Abstract:
In long-term clinical trials, interim analyses are planned to reduce the number of patients needed. To meet this issue in a practical way, group sequential designs are used. Most of these trials are conducted with the objective of demonstrating differences in efficacy of treatments, for example, to show superiority of a new drug or experimental treatment to a control. However, an increasing number of trials are designed to establish equivalence in efficacy or bioequivalence. This paper deals with group sequential test procedures in two-sided equivalence trials. Optimized designs with respect to sample size behaviour are constructed. Tables containing optimal testing times and corresponding optimal critical values or values to construct an underlying alpha-spending function, respectively, are provided. An example illustrates their use when planning interim analyses in equivalence trials.
Related Concept Videos
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Comparison Tests
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Equivalence: In Vitro and In Vivo Bioequivalence
Bonferroni Test
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
Significance Testing: Overview